Classification of Breast Cancer Through the Perspective of Cell Identity Models
- PMID: 39821027
- DOI: 10.1007/978-3-031-70875-6_11
Classification of Breast Cancer Through the Perspective of Cell Identity Models
Abstract
The mammary epithelium has an inner luminal layer that contains estrogen receptor (ER)-positive hormone-sensing cells and ER-negative alveolar/secretory cells, and an outer basal layer that contains myoepithelial/stem cells. Most human tumours resemble either hormone-sensing cells or alveolar/secretory cells. The most widely used molecular classification, the Intrinsic classification, assigns hormone-sensing tumours to Luminal A/B and human epidermal growth factor 2-enriched (HER2E)/molecular apocrine (MA)/luminal androgen receptor (LAR)-positive classes, and alveolar/secretory tumours to the Basal-like class. Molecular classification is most useful when tumours have classic invasive carcinoma of no special type (NST) histology. It is less useful for special histological types of breast cancer, such as metaplastic breast cancer and adenoid cystic cancer, which are better described with standard pathology terms. Compared to mice, humans show a strong bias towards making tumours that resemble mammary hormone-sensing cells. This could be caused by the formation in adolescence of der(1;16), a translocation through the centromeres of chromosomes 1 and 16, which only occurs in humans and could trap the cells in the hormone-sensing state.
Keywords: Basal-like breast cancer; Breast cancer cell of origin; HER2-enriched breast cancer; Luminal AR breast cancer; Mammary lineage; Molecular apocrine breast cancer; Triple-negative breast cancer; der(1;16) translocation.
© 2025. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.Jpn J Clin Oncol. 2012 May;42(5):375-86. doi: 10.1093/jjco/hys034. Epub 2012 Mar 26. Jpn J Clin Oncol. 2012. PMID: 22450930
-
Identification of molecular apocrine breast tumours by microarray analysis.Oncogene. 2005 Jul 7;24(29):4660-71. doi: 10.1038/sj.onc.1208561. Oncogene. 2005. PMID: 15897907
-
Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.BMC Cancer. 2019 Dec 30;19(1):1267. doi: 10.1186/s12885-019-6483-6. BMC Cancer. 2019. PMID: 31888566 Free PMC article.
-
The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling.J Mammary Gland Biol Neoplasia. 2011 Apr;16(1):51-5. doi: 10.1007/s10911-011-9202-8. Epub 2011 Feb 19. J Mammary Gland Biol Neoplasia. 2011. PMID: 21336547 Review.
-
Clinical Implications of Breast Cancer Intrinsic Subtypes.Adv Exp Med Biol. 2025;1464:435-448. doi: 10.1007/978-3-031-70875-6_21. Adv Exp Med Biol. 2025. PMID: 39821037 Review.
Cited by
-
Soy and Isoflavones: Revisiting Their Potential Links to Breast Cancer Risk.Nutrients. 2025 Aug 13;17(16):2621. doi: 10.3390/nu17162621. Nutrients. 2025. PMID: 40871649 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous